Latest news for Orion (OTC:ORINF) Stock

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

ORION CORP NEW B SHS by Orion Corporation OY

Orion Oyj

Orion collaborates with Glykos to develop next-generation ADCs

Orion Oyj GAAP EPS of €0.54, revenue of €321.1M

Orion Oyj (ORINF) Q4 2023 Earnings Call Transcript

Orion Oyj goes ex dividend tomorrow

ORION Holdings reports Q1 results

ORION Holdings Corp. (ORINF) Q1 2024 Earnings Call Transcript

ORION Holdings reports Q2 results

ORION Holdings Corp. (ORINF) Q2 2024 Earnings Call Transcript

ORINF

ORINY

Orion

Comments

Orion

News

Latest news for Orion (OTC:ORINF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga